Form 4: Aura Biosciences Chief Medical Officer Sells Shares to Cover Tax Obligations

Aura Biosciences' Chief Medical Officer, Janet Jill Hopkins, sold 11,822 shares of common stock to cover tax obligations related to vesting restricted stock units.

Summary

• Janet Jill Hopkins, Chief Medical Officer of Aura Biosciences, sold 11,822 shares of common stock on November 18, 2024.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $9.3608, with individual transactions ranging from $9.36 to $9.48 per share.
• Following the transaction, Ms. Hopkins directly owns 151,693 shares of Aura Biosciences common stock.
• A power of attorney was granted to Conor Kilroy and Amy Elazzouzi to handle SEC filings related to the company's securities.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment. It is a neutral event.

Industry Context

This is a routine transaction for company insiders to manage their tax obligations related to stock-based compensation. It is common for executives to sell shares to cover taxes when restricted stock units vest.

Comparison to Industry Standards

• Sales of shares by executives to cover tax obligations are a common practice across the industry.
• The sale of 11,822 shares by the Chief Medical Officer is not unusual for a company of Aura Biosciences' size and stage.
• Similar transactions are regularly reported by executives at comparable biotech companies.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on the stock price, but it is generally considered a routine transaction.

Key Dates

Keywords

Aura Biosciences, insider trading, Form 4, stock sale, Janet Jill Hopkins, Chief Medical Officer, restricted stock units, tax obligations, securities, SEC